FDA inspection
Linde Inc.: FDA inspection ending Jun 18, 2026
FDA inspection 1322980 · Voluntary Action Indicated (VAI) · Niagara Falls, NY
Key facts
| Inspection ID | 1322980 |
|---|---|
| Firm | Linde Inc. |
| FEI number | 1312847 |
| Address | 4501 Royal Ave |
| City | Niagara Falls |
| State | NY |
| ZIP | 14303 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Jun 18, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data